Matthew Zimmerman

Also affiliated with Center for Discovery

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Inhibition of Fatty Acid Oxidation Promotes Macrophage Control of Mycobacterium tuberculosis”.

Inhibition of Fatty Acid Oxidation Promotes Macrophage Control of Mycobacterium tuberculosis

mBio(2020)10.1128/mbio.01139-20

N/A

0DataRank · unranked

84 citations

Li He, Matthew Zimmerman, Guozhe Yang, Stefan Köster, Mireille Ouimet +6 more

A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

Cell chemical biology(2020)10.1016/j.chembiol.2020.02.007

N/A

0DataRank · unranked

42 citations

Divya Awasthi, Glenn C. Capodagli, Kholiswa Tsotetsi, Paridhi Sukheja, Matthew Zimmerman +20 more

A Semisynthetic Kanglemycin Shows In Vivo Efficacy against High-Burden Rifampicin Resistant Pathogens

ACS Infectious Diseases(2020)10.1021/acsinfecdis.0c00223

N/A

0DataRank · unranked

18 citations

Jiayi Xu, Han Wang, Shraddha Suryavanshi, Matthew Zimmerman, Riccardo Russo +4 more

Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates

European Journal of Pharmaceutical Sciences(2020)10.1016/j.ejps.2020.105421

N/A

0DataRank · unranked

10 citations

Charles A. Scanga, Carolina de Miranda Silva, Matthew Zimmerman, Chelsea M. Causgrove, Brianne Stein +8 more

Tissue Distribution of Doxycycline in Animal Models of Tuberculosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.02479-19

N/A

0DataRank · unranked

44 citations

Matthew Zimmerman, Jansy P. Sarathy, Firat Kaya, Han Wang, Marizel Mina +8 more

Antitubercular nanocarrier monotherapy: Study of In Vivo efficacy and pharmacokinetics for rifampicin

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.02.026

N/A

0DataRank · unranked

40 citations

Oto Pavliš, Pavla Kubíčková, Miša Škorič, V. Marešová, Ewa Pavlová +7 more

Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00024-21

N/A

0DataRank · unranked

25 citations

Jansy P. Sarathy, Kamunkhwala Gausi, Matthew Zimmerman, Han Wang, Gert-Jan Wijnant +10 more

Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab043

N/A

0DataRank · unranked

22 citations

Lina Keutzer, Aart van der Meijden, Sanne van den Berg, Han Wang, Matthew Zimmerman +4 more

Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs

PLoS Biology(2021)10.1371/journal.pbio.3001355

N/A

0DataRank · unranked

21 citations

Calvin M. Johnson, Yong‐Mo Ahn, Kyle M. Kremiller, Matthew Sherwood, Jimmy S. Patel +10 more

Potency boost of a Mycobacterium tuberculosis dihydrofolate reductase inhibitor by multienzyme F 420 H 2 -dependent reduction

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2025172118

N/A

0DataRank · unranked

17 citations

Brendon M. Lee, Xuan Yang, Matthew Zimmerman, Martin Gengenbacher, Véronique Dartois +4 more

Structure, In Vivo Detection, and Antibacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate

ACS Infectious Diseases(2021)10.1021/acsinfecdis.1c00259

N/A

0DataRank · unranked

16 citations

Matthew Zimmerman, Nadine Álvarez, Jansy P. Sarathy, Véronique Dartois, Carol A. Nacy +2 more

A chemical-genetic map of the pathways controlling drug potency in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.27.469863

N/A

0DataRank · unranked

4 citations

Nicholas C. Poulton, Jesseon S. Chang, Zachary A. Azadian, Michael A. DeJesus, Nadine Ruecker +10 more

Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.08.439092

N/A

0DataRank · unranked

2 citations

Peter O. Oluoch, Nadine Ruecker, Megan K. Proulx, Vijay Soni, Kenan C. Murphy +19 more

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis

Nature Microbiology(2022)10.1038/s41564-022-01130-y

N/A

0DataRank · unranked

234 citations

Nicholas C. Poulton, Jesseon S. Chang, Zachary A. Azadian, Michael A. DeJesus, Nadine Ruecker +10 more

CinA mediates multidrug tolerance in Mycobacterium tuberculosis

Nature Communications(2022)10.1038/s41467-022-29832-1

N/A

0DataRank · unranked

52 citations

Robert S. Jansen, Travis Hartman, Alexandre Gouzy, Ruojun Wang, Inna V. Krieger +10 more

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions

ACS Infectious Diseases(2022)10.1021/acsinfecdis.1c00570

N/A

0DataRank · unranked

25 citations

Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood +39 more

Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance

Angewandte Chemie International Edition(2022)10.1002/anie.202211498

N/A

0DataRank · unranked

23 citations

Uday S. Ganapathy, Sachin Sharma, Yong‐Mo Ahn, Matthew Zimmerman, Vadim Molodtsov +8 more

Drug concentration at the site of disease in children with pulmonary tuberculosis

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac103

N/A

0DataRank · unranked

6 citations

Ahmed A. Abulfathi, Natasha Strydom, Pierre Goussard, Abraham C. van Wyk, Anne Marie Demers +16 more

Development of amidase-dependent pyrazinoic acid prodrugs with activity against pyrazinamide resistant Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.05.496887

N/A

0DataRank · unranked

1 citations

Ravindra D. Jadhav, Yan Pan, Kholiswa Tsotetsi, Xin Wang, Divya Awasthi +18 more

The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability

mBio(2023)10.1128/mbio.00353-23

N/A

0DataRank · unranked

6 citations

Matthew Zimmerman, Sandra D. Oland, Han Wang, Lara Mittereder, Véronique Dartois +2 more

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.03.527062

N/A

0DataRank · unranked

0 citations

Jackie P. Ernest, Christian Dide-Agossou, Allison Bauman, Michelle E. Ramey, Karen Rossmassler +12 more

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling

Viruses(2024)10.3390/v16071158

N/A

0DataRank · unranked

5 citations

Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more

Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408

Bioorganic & Medicinal Chemistry Letters(2024)10.1016/j.bmcl.2024.129934

N/A

0DataRank · unranked

2 citations

Pradeep B. Lukka, Victoria Ektnitphong, Keyur Parmar, Santosh Wagh, Yan Lü +11 more

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological Profiling

Preprints.org(2024)10.20944/preprints202406.1311.v1

N/A

0DataRank · unranked

1 citations

Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more

The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf303

N/A

0DataRank · unranked

6 citations

Jacqueline P. Ernest, Firat Kaya, Connie Silva, Jansy P. Sarathy, Landry Blanc +11 more